Skip to main content

Table 2 The demographic and laboratory parameters of CKD patients above and below median TG/HDL-C ratio

From: The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease

 

TG/HDL-Cratio

TG/HDL-Cratio

*P value

<3.29

>3.29

ADMA (μmol/l)

2.7 ± 1.6

3.2 ± 1.7

0.04

PTH (pg/ml)

122.5 ± 88.4

154.2 ± 101.1

0.02

eGFR (ml/min)

56.7 ± 33.4

46.6 ± 31.7

0.03

FMD (%)

7.2 ± 1.3

6.5 ± 1.2

<0.001

hsCRP (mg/l)

14.6 ± 7.8

16.0 ± 8.1

0.21

SBP (mmHg)

133.3 ± 8.2

136.1 ± 11.9

0.06

DBP (mmHg)

84.2 ± 4.4

84.5 ± 5.1

0.57

HOMA-IR

1.7 ± 0.7

1.8 ± 0.7

0.90

Age (years)

52 ± 12

54 ± 12

0.08

Gender (M/F)

51/47

50/49

0.89

BMI (kg/m 2 )

26.1 ± 2.8

26.2 ± 2.8

0.88

Total Cholesterol (mg/dl)

191.3 ± 23.9

201.2 ± 23.5

0.04

Triglyceride (mg/dl)

131.3 ± 15.8

150.5 ± 18.3

<0.001

LDL-cholesterol (mg/dl)

125.9 ± 16.4

129.6 ± 21.6

0.18

HDL-cholesterol (mg/dl)

47.1 ± 6.9

37.3 ± 6.2

<0.001

Triglyceride/HDL-C ratio

2.8 ± 0.4

4.2 ± 1.1

<0.001

Albumin (g/dl)

3.9 ± 0.3

4.0 ± 0.4

0.29

Calcium (mg/dl)

8.5 ± 0.6

8.4 ± 0.5

0.29

Phosphate (mg/dl)

4.9 ± 1.4

5.6 ± 1.7

0.01

NMD (%)

12.9 ± 0.6

12.7 ± 0.8

0.71

  1. *Student’s t test.